Study of IBI3016 in Japanese adults with high blood pressure
Part of Heart & circulation clinical trials.
This trial tests an experimental drug called IBI3016 for lowering high blood pressure. It is specifically for Japanese adults who have high blood pressure while currently on treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You were born in Japan and your parents and grandparents were also born in Japan.
- Your systolic blood pressure (the top number) is between 140 and 170 mmHg when measured in a clinic.
- You do not have certain conditions like sleep apnea or a history of dizziness when standing up.
- You are not currently taking or have not previously had problems with blood pressure medications called ACE inhibitors, ARBs, ARNI, or direct renin inhibitors.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage trial tests a new blood pressure medication called HJB647 in Japanese adults with elevated or high blood pressure. The study aims to see if the drug is safe and how the body handles it.
This study tests a new blood pressure medication to see if it is safe and effective for people with high blood pressure. It may help lower your blood pressure and reduce health risks.
This trial tests a new treatment called CTX340 for high blood pressure that is hard to control even with multiple medications. The study aims to see if it is safe and effective.
This study tests a blood pressure medication (an angiotensin receptor-neprilysin inhibitor, or ARNi) in adults with high blood pressure in the United Arab Emirates. It looks at how well the medicine works in real life, and may be an option if you are just starting treatment or already taking one blood pressure pill.
This study tests an injectable medicine (IBI362) to see if it helps lower blood pressure in people who are overweight or have obesity. You may be eligible if you have high blood pressure but are not currently taking medication for it, and you do not have diabetes or major heart problems.
This study tests a new medicine called KK3910, first in healthy volunteers to check safety, then in Japanese patients with essential hypertension (high blood pressure) to see if it helps lower blood pressure.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.